1 of 1
Story summary
- Dr. Hidehiro Kaneko’s team found stage 3 CKM syndrome raises cancer risk by 25% and stage 4 by 30% versus stage 0.
- They analyzed national insurance claims for about 1.4 million Japanese adults over 3½ years.
- After adjusting for age, sex, smoking, alcohol and weight, stage 1 and stage 2 showed 3% and 2% higher cancer risks.
- The authors linked the findings to chronic inflammation, oxidative stress and metabolic disturbances, noting the Japan-only sample may limit generalizability.
